 |
SAN ANTONIO, Sept. 18, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the real-world evidence analytics (RWE) solutions industry and, based on its findings, recognizes OM1 with the 2024 North American New Product Innovation Award. OM1 is a leading technology company with expertise in personalized medicine, evidence generation, and RWE research. The company leverages its next-generation AI platforms and research-grade longitudinal data to enable pharmaceutical companies, healthcare providers, and researchers to gain deeper insights into patient outcomes, disease progression, and treatment efficacy.